Abstract:Head and neck squamous cell carcinoma (HNSCC) is a solid tumor composed by a genotypically and phenotypically heterogeneous population of neoplastic cells types. High recurrence rate and regional metastases lead to major morbidity and mortality. Recently, many studies have focused on cellular and molecular mechanisms of tumor progression that can help to predict prognosis and to choose the best therapeutic approach for HNSCC patients. Hyaluronan (HA), an important glycosaminoglycan component of the extracellular matrix (ECM), and its major cell surface receptor, CD44, have been suggested to be important cellular mediators influencing tumor progression and treatment resistance in head and neck cancer. HNSCC contains a small subpopulation of cells that exhibit a hallmark of CD44-expressing cancer stem cell (CSC) properties with self-renewal, multipotency, and a unique potential for tumor initiation. HA has been shown to stimulate a variety of CSC functions including self-renewal, clone formation and differentiation. This review article will present current evidence for the existence of a unique small population of CD44v3highALDHhigh-expressing CSCs in HNSCC. A special focus will be placed on the role of HA/CD44-induced oncogenic signaling and histone methyltransferase, DOT1L activities in regulating histone modifications (via epigenetic changes) and miRNA activation. Many of these events are essential for the CSC properties such as Nanog/Oct4/Sox2 expression, spheroid/clone formation, self-renewal, tumor cell migration/invasion, survival and chemotherapeutic drug resistance in HA-activated head and neck cancer. These newly-discovered HA/CD44-mediated oncogenic signaling pathways delineate unique tumor dynamics with implications for defining the drivers of HNSCC progression processes. Most importantly, the important knowledge obtained from HA/CD44-regulated CSC signaling and functional activation could provide new information regarding the design of novel drug targets to overcome current therapeutic drug resistance which will have significant treatment implications for head and neck cancer patients.

Epithelial-to-mesenchymal Transition and Cancer Stem(-Like) Cells in Head and Neck Squamous Cell Carcinoma

Biomarkers Of Head And Neck Cancer Stem Cells And Targeted Therapeutic Strategies

Epithelial–Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review

Stem Cells in Squamous Head and Neck Cancer

Targeting Cancer Stem Cells In Squamous Cell Carcinoma

Transcription Factors and Markers Related to Epithelial–Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers

The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

Links between cancer stem cells and epithelial-mesenchymal transition.

Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities

Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review

The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis

Epithelial‐derived head and neck squamous tumourigenesis (Review)

Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights into Cancer Progression

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma

Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells

MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.

Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.

Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer-Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies

Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium

Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours